Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

120.66 -0.36 (-0.30%)
Streaming Delayed Price Updated: 12:28 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
46 47 Next >
Emery Pharma Announces New Biologics Analytical Division
Supporting end-to-end research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars, and more 
Via Newswire.com
A Look Into Healthcare Sector Value Stocks
  Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
Via Benzinga
Novartis' Lung Cancer Candidate Misses Primary Goal In Post Surgery Setting
Via Benzinga
The Most Expensive Drug From Novartis Associated With Two Deaths: Report
Two children with spinal muscular atrophy have died after receiving Novartis AG's (NYSE: NVS) Zolgensma, a one-time gene therapy, spotlighting its risks and questioning the safety of genetic medicines... 
Via Benzinga
This Nasal Spray For Eye Disease Stock Is 'Attractive', Has Potential 160% Upside
Via Benzinga
Recap: Novartis Q2 Earnings
  Novartis (NYSE:NVS) reported its Q2 earnings results on Tuesday, July 19, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pioneering Innovative Hypertension Treatments
Via Investor Brand Network
Topics Intellectual Property
Deciphera's Cancer Drug Tops Pfizer's Sutent On Safety Front In Gastrointestinal Cancer
Via Benzinga
Laboratory Testing Leader Pace® Science and Technology Company Names Nisheet Gupta as New Chief Financial Officer
Experienced financial leader Nisheet Gupta has been appointed Executive Vice President and Chief Financial Officer of Twin Cities-based Pace®, a leader and innovator in testing, analysis, and... 
Via Newswire.com
Vizzia Technologies Named a Top 100 Healthcare Technology Company of 2022
Real-Time Data Analytics Service Provider Recognized for 2nd Consecutive Year 
Via Newswire.com
The Power of Science to Stop a Killer
Via Investor Brand Network
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
An estimated 200 million Americans — more than 60% of the population — suffer from at least one neurological disorder. That includes dementia, strokes, migraines and other diseases or infections that... 
Via Benzinga
The Power of Science to Stop a Killer
NetworkNewsWire Editorial Coverage New York, NY – August 8, 2022 – Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114... 
Via FinancialNewsMedia
Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024
Via Benzinga
Death Cross Looms Over Novartis Investors
If history is any guide, there may be trouble ahead for shares of Novartis (NYSE:NVS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
Mark Cuban Says Americans Shouldn't Have To Pick Between Rent, Food Or Medicine
Famed billionaire, entrepreneur and Dallas Maverick’s owner Mark Cuban thinks Americans shouldn’t have to pick between necessities such as food, medicine or rent. And he’s provided a solution for at... 
Via Benzinga
Amphetamine Drug Market 2022: Industry Analysis, Size, Global Trends, Share, Growth, Opportunity and Forecast to 2028
Amphetamine Drug Market SWOT Analysis Including Key Players Pfizer, Novartis, Eli Lilly, GSK, Hisamitsu Pharmaceutical, Purdue Pharma 
Via SBWire
This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence
BioRestorative Therapies Inc. (NASDAQ: BRTX), a stem cell-focused biotech, says it wants to shift the paradigm of how doctors treat chronic pain in hopes of giving patients an option that’s effective,... 
Via Benzinga
7 Cathie Wood Stocks Trading at a Discount Right Now
These 7 Cathie Wood stocks are the best choices to buy in June. COIN, FATE, NTLA, MELI, TDOC, TSLA, and ZM can make excellent investments. 
Via InvestorPlace
As Snap Spooks Market, Here Are The Hits & Misses Of Q2 Reporting Season
Snap, Inc. (NYSE: SNAP) was among the high-profile disappointment thus far in the second-quarter reporting season. 
Via Benzinga
Stock Market Rally Breaks Higher; Tesla, Netflix, Snap, United Airlines Key Earnings: Weekly Review
But a slew of earnings reports and another big Fed rate hike loom. 
Via Investor's Business Daily
New Indication Approval For Incyte "To Usher New Growth Avenue"
Via Benzinga
HC Wainwright Starts Coverage On This 'Best-In-Class Agent For Inflammatory Disorders
Via Benzinga
Ford, General Motors Rally; Check These Other Big Gainers From Yesterday
U.S. stocks closed sharply higher, with the Dow Jones gaining more than 750 points on Tuesday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) jumped 50.1% to $1.5907 after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue... 
Via Benzinga
Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and... 
Via Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Novartis Beats Second-Quarter Earnings Goal But Sales Light
Swiss drugmaker Novartis on Tuesday delivered better-than-expected earnings for the second quarter but sales were light. Novartis stock rose. 
Via Investor's Business Daily
IBM And 20 Stocks Moving Premarket
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) rose 32.1% to $1.40 in pre-market trading after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised... 
Via Benzinga
Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.